Zytiga Approved for Advanced Prostate Cancer
(HealthDay): "HealthDay - FRIDAY, April 29 (HealthDay News) -- Zytiga (abiraterone
acetate), used in combination with the steroid prednisone, has been
approved to treat advanced prostate cancer, the U.S. Food and Drug
Administration said in a news release."
The most common adverse reactions to the drug combination included joint discomfort, low blood potassium, fluid retention, muscle discomfort, hot flashes, diarrhea, urinary tract infection, cough, high blood pressure, heartbeat abnormalities, increased urinary frequency, upset stomach and upper respiratory infection.
